SAN FRANCISCO--(BUSINESS WIRE)--Jul 12, 2018--McKesson Corporation today praised the U.S. Department of Justice’s decision to exercise its authority to reduce opioid production if the agency believes a particular drug is highly diverted.

“We applaud this common-sense action by the Department of Justice. The annual opioid production quota determines the total amount of controlled substances that can be produced each year. That authority is significant as the nation struggles to address the current public health crisis around opioid addiction. This new rule calls on the Drug Enforcement Administration to carefully assess which drugs are being diverted – an important part of the effort to curb opioid misuse and abuse.”

In October 2017, McKesson called on the DEA to revise its annual production quota for opioids.

McKesson is deeply concerned by the impact the opioid epidemic is having on families and communities across the nation—and is committed to being part of the solution. The company has formed an independent foundation dedicated to addressing the crisis, to which McKesson contributed $100 million. The company is also advancing aimed at preventing opioid abuse and has offered thoughtful , including the (RxSAS) technology proposal.

To learn more about McKesson’s comprehensive efforts to address the opioid epidemic, please visit:  www.McKesson.com/FightingOpioidAbuse.

About McKesson Corporation

McKesson Corporation, currently ranked 5 th  on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help make the right medicines, medical products and healthcare services available to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “ Most Admired Company ” in the healthcare wholesaler category by FORTUNE, a “ Best Place to Work ” by the Human Rights Campaign Foundation, and a top  military-friendly company  by Military Friendly. For more information, visit  mckesson.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180712005857/en/

CONTACT: McKesson Corporation

April Marks, 415-732-1384

April.Marks@McKesson.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT SUPPLY CHAIN MANAGEMENT HEALTH PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM PHARMACEUTICAL OTHER POLICY ISSUES WHITE HOUSE/FEDERAL GOVERNMENT RETAIL

SOURCE: McKesson Corporation

Copyright Business Wire 2018.

PUB: 07/12/2018 04:19 PM/DISC: 07/12/2018 04:19 PM

http://www.businesswire.com/news/home/20180712005857/en